NCT04147481 Effects of Abdominal Nerve Block on Postoperative Recovery in Patients Undergoing Gastrointestinal Surgery Status UNKNOWN Phase NA
NCT04140526 Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04139135 A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancer Status UNKNOWN Phase PHASE3
NCT04116320 Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT04108494 A Trial of Total Versus Partial Omentectomy for Advanced Gastric Cancer in Gastrectomy Status RECRUITING Phase NA
NCT04107142 Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour Status UNKNOWN Phase PHASE1
NCT04107077 Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer Status RECRUITING Phase PHASE2
NCT04106167 Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy Status TERMINATED Phase N/A
NCT04105062 LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery Status WITHDRAWN Phase PHASE1/PHASE2
NCT04099641 An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients Status COMPLETED Phase PHASE2
NCT04086888 Real World Study of Immune Checkpoint Inhibitors for Advanced Gastric Cancer Status UNKNOWN Phase N/A
NCT04082364 Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT04077372 Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers Status TERMINATED Phase NA